Read this article:
TG Therapeutics Announces FDA Accelerated Approval of UKONIQ™ (umbralisib)

Read the rest here:
Zentalis Pharmaceuticals to Participate in Two Upcoming Investor Conferences

See the article here:
Tauriga Sciences Inc. Showcases its Virtual Booth as a Corporate Exhibitor at 2021 CTIC Capital Pre-J.P. Morgan Healthcare Investor Summit This...

Read more:
Data from Vallon Pharmaceuticals’ ADAIR Selected for Symposia Presentation at the Virtual 2021 APSARD Annual Meeting

Read the original:
Sorrento Announces Positive Preliminary Results of Phase 1b Study of COVI-MSC™ for Treatment of ICU COVID-19 Patients

See original here:
Evaxion Biotech Announces Filing of Registration Statement in the U.S. for Proposed Initial Public Offering of Securities

Original post:
Eloxx Pharmaceuticals to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference

View post:
Pfizer and BioNTech to Submit Emergency Use Authorization Request Today to the U.S. FDA for COVID-19 Vaccine

Read more from the original source:
Gilead  and  Galapagos  announce  New  Commercialization  and  Development  Agreement  for  Jyseleca®  (filgotinib)  

Go here to read the rest:
Adamas to Present at Upcoming Piper Sandler Conference

More here:
Diabetes Freedom Reviews: Does George Reilly Program Book Really Work?

Read this article:
Equillium Announces Positive Interim Data of Itolizumab in the First-line Treatment of Acute Graft-Versus-Host Disease

Follow this link:
Annexon Expands Classical Complement Platform into Neurodegenerative Diseases of the Brain with Initiation of Huntington’s Disease Clinical Program

Read the original here:
Ascendis Pharma A/S Announces Third Quarter 2020 Financial Results and Business Update Conference Call on November 11

Go here to read the rest:
Bellerophon Provides Clinical Program Update and Reports Third Quarter 2020 Financial Results

Continued here:
BioVie Interview to Air on Bloomberg International on the RedChip Money Report

See original here:
Teneobio Announces a Research Collaboration and License Agreement With ArsenalBio

See original here:
Telo Genomics Announces Warrant Exercise Agreement

See original here:
Greenwich Biosciences, Inc., a Subsidiary of GW Pharmaceuticals plc, Launches unspoken symphony, a Breakthrough Innovation Created for the US Epilepsy...

See the original post here:
Opiant Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)